Articles published by Beam Therapeutics
From Beam Therapeutics
Via GlobeNewswire
Tickers
BEAM
Beam Therapeutics Appoints Biotech Executive Christi Shaw to its Board of Directors
December 14, 2023
From Beam Therapeutics
Via GlobeNewswire
Tickers
BEAM
From Beam Therapeutics
Via GlobeNewswire
Tickers
BEAM
Beam Therapeutics Reports Pipeline and Business Updates and Third Quarter 2023 Financial Results
November 08, 2023
From Beam Therapeutics
Via GlobeNewswire
Tickers
BEAM
Beam Therapeutics Announces First Patient Dosed in Phase 1/2 Trial of BEAM-201 in Relapsed, Refractory T-ALL/T-LL
September 05, 2023
From Beam Therapeutics
Via GlobeNewswire
Tickers
BEAM
From Beam Therapeutics
Via GlobeNewswire
Tickers
BEAM
Beam Therapeutics Reports Pipeline Updates and Second Quarter 2023 Financial Results
August 08, 2023
From Beam Therapeutics
Via GlobeNewswire
Tickers
BEAM
From Beam Therapeutics
Via GlobeNewswire
Tickers
BEAM
Beam Therapeutics to Participate in RBC Capital Markets 2023 Global Healthcare Conference
May 11, 2023
From Beam Therapeutics
Via GlobeNewswire
Tickers
BEAM
From Beam Therapeutics
Via GlobeNewswire
Tickers
BEAM
Beam Therapeutics to Participate in the Guggenheim 2023 Genomic Medicines and Rare Disease Day
March 27, 2023
From Beam Therapeutics
Via GlobeNewswire
Tickers
BEAM
From Beam Therapeutics
Via GlobeNewswire
Tickers
BEAM
From Beam Therapeutics
Via GlobeNewswire
Tickers
BEAM
From Beam Therapeutics
Via GlobeNewswire
Tickers
BEAM
Beam Therapeutics Reports Fourth Quarter and Year-End 2022 Financial Results and Reiterates Anticipated Milestones
February 28, 2023
From Beam Therapeutics
Via GlobeNewswire
Tickers
BEAM
Beam Therapeutics to Participate in the SVB Securities Virtual Global Biopharma Conference
February 07, 2023
From Beam Therapeutics
Via GlobeNewswire
Tickers
BEAM
Beam Therapeutics Reports Progress Across Base Editing Portfolio and Outlines Key Anticipated Milestones
January 09, 2023
From Beam Therapeutics
Via GlobeNewswire
Tickers
BEAM
From Beam Therapeutics
Via GlobeNewswire
Tickers
BEAM
From Beam Therapeutics
Via GlobeNewswire
Tickers
BEAM
Beam Therapeutics Announces FDA Has Lifted the Clinical Hold on the Investigational New Drug Application for BEAM-201
December 02, 2022
From Beam Therapeutics
Via GlobeNewswire
Tickers
BEAM
Beam Therapeutics to Participate in the BofA Securities 2022 Virtual Biotech SMID Cap Conference
November 30, 2022
From Beam Therapeutics
Via GlobeNewswire
Tickers
BEAM
Beam Therapeutics to Participate in Upcoming Investor Conferences
November 09, 2022
From Beam Therapeutics
Via GlobeNewswire
Tickers
BEAM
Beam Therapeutics Announces Portfolio Progress and Reports Third Quarter 2022 Financial Results
November 07, 2022
From Beam Therapeutics
Via GlobeNewswire
Tickers
BEAM
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.